Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fereshteh Azimian

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Medicinal Chemistry|September 20, 2022
Recent Advances in Structural Modification Strategies for Lead Optimization of Tyrosine Kinase Inhibitors to Explore Novel Anticancer AgentsFereshteh Azimian, Siavoush Dastmalchi
European Journal of Medicinal Chemistry|July 15, 2020
Synthesis and biological evaluation of diaryl urea derivatives designed as potential anticarcinoma agents using de novo structure-based lead optimization approachFereshteh Azimian, Maryam Hamzeh-Mivehroud, Javid Shahbazi Mojarrad, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2026
Small molecules targeting ARF1 interaction with C9orf72:SMCR8:WDR41 complexes suppress its overactivation implicated in ALS/FTDEmma Dixon, Fereshteh Azimian, Angelina Joby Chacko, et al.
Communications Chemistry|November 20, 2024
Enabling systemic identification and functionality profiling for Cdc42 homeostatic modulatorsSatyaveni Malasala, Fereshteh Azimian, Yan-Hua Chen, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Enabling Systemic Identification and Functionality Profiling for Cdc42 Homeostatic ModulatorsSatyaveni Malasala, Fereshteh Azimian, Yan-Hua Chen, et al.
Bioorganic & Medicinal Chemistry Letters|December 13, 2022
Synthesis, anticancer evaluation, and molecular docking studies of thiazolyl-pyrazoline derivativesNarges Hosseini Nasab, Fereshteh Azimian, Rok Su Shim, et al.
BMC Chemistry|April 23, 2025
Structure-activity relationship guided design, synthesis and biological evaluation of novel diaryl urea derivatives as antiproliferative agentsFereshteh Azimian, Narges Cheshmazar, Narges Hosseini Nasab, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Medicinal Chemistry|September 20, 2022
Recent Advances in Structural Modification Strategies for Lead Optimization of Tyrosine Kinase Inhibitors to Explore Novel Anticancer AgentsFereshteh Azimian, Siavoush Dastmalchi
European Journal of Medicinal Chemistry|July 15, 2020
Synthesis and biological evaluation of diaryl urea derivatives designed as potential anticarcinoma agents using de novo structure-based lead optimization approachFereshteh Azimian, Maryam Hamzeh-Mivehroud, Javid Shahbazi Mojarrad, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2026
Small molecules targeting ARF1 interaction with C9orf72:SMCR8:WDR41 complexes suppress its overactivation implicated in ALS/FTDEmma Dixon, Fereshteh Azimian, Angelina Joby Chacko, et al.
Communications Chemistry|November 20, 2024
Enabling systemic identification and functionality profiling for Cdc42 homeostatic modulatorsSatyaveni Malasala, Fereshteh Azimian, Yan-Hua Chen, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Enabling Systemic Identification and Functionality Profiling for Cdc42 Homeostatic ModulatorsSatyaveni Malasala, Fereshteh Azimian, Yan-Hua Chen, et al.
Bioorganic & Medicinal Chemistry Letters|December 13, 2022
Synthesis, anticancer evaluation, and molecular docking studies of thiazolyl-pyrazoline derivativesNarges Hosseini Nasab, Fereshteh Azimian, Rok Su Shim, et al.
BMC Chemistry|April 23, 2025
Structure-activity relationship guided design, synthesis and biological evaluation of novel diaryl urea derivatives as antiproliferative agentsFereshteh Azimian, Narges Cheshmazar, Narges Hosseini Nasab, et al.
Pageof 1